Tandem Health

Healthtech · AI · Clinical Software

Funding

Tandem Health raises $100M Series B to build AI clinic operating system

A newly EU-backed scale-up fund is betting Europe needs homegrown clinical AI instead of retrofitted American tools.

• Tandem Health closed a $100M Series B led by the EU-backed Scaleup Europe Fund, managed by EQT, with existing investors Kinnevik, Northzone, Amino Collective and Visionaries participating.
• The Stockholm-based startup's LLM-powered co-pilot generates medical notes, coding and clinical decision support during patient visits, and is now used by 10,000 care organizations across 14 European markets.
• The round follows a $50M Series A in 2025 and brings Tandem's total funding to $160M; the company did not disclose its valuation.
• Peer-reviewed research cited by Tandem shows clinicians using its tool report a 29% reduction in admin time, a 30% rise in job satisfaction and a 30% drop in administrative stress.
• This is the Scaleup Europe Fund's first healthcare investment, following bets on French AI company Mistral and Finnish satellite startup Iceye.
• Tandem plans to evolve from a medical-assistant tool into a full 'AI-native clinic operating system' that manages patient flows and enables additional clinical agents across Europe.
• The deal signals that EU public-backed capital now treats clinical AI as strategic infrastructure, aiming to keep healthcare software European-owned rather than ceding the market to U.S. incumbents.